scispace - formally typeset
T

Thomas Fröhlich

Researcher at Ludwig Maximilian University of Munich

Publications -  140
Citations -  5294

Thomas Fröhlich is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Proteome & Medicine. The author has an hindex of 34, co-authored 120 publications receiving 4089 citations. Previous affiliations of Thomas Fröhlich include Center for Integrated Protein Science Munich.

Papers
More filters
Journal ArticleDOI

Characterization of the sebocyte lipid droplet proteome reveals novel potential regulators of sebaceous lipogenesis.

TL;DR: In this article, the authors used qRT-PCR to confirm expression of transcripts encoding the six previously unidentified proteins, ALDH1A3 and EPHX4, in SZ95 sebocytes and in another sebocyte line (SebE6E7).

Proteomic Characterization of Archaeal Ribosomes Reveals the Presence of Novel Archaeal-Specific

TL;DR: This study reports the first comprehensive two-dimensional PAGE and mass spectrometry analysis of archaeal ribosomes isolated from the thermophilic Pyrobaculum aerophilum and the thermoacidophilic Sulfolobus acidocaldarius Crenarchaeota, and identifies three hypothetical proteins that appear to be bona fide r-proteins of the S. acidOCaldarius large subunit.
Journal ArticleDOI

Analysis of the HUPO Brain Proteome reference samples using 2-D DIGE and 2-D LC-MS/MS.

TL;DR: Within the HUPO BPP brain protein database, a robust 2‐D LC‐MS/MS method was applied to murine postnatal day 7 and human post‐mortem brain samples and 350 human and 481 mouse proteins could be identified by at least two different peptides.
Journal ArticleDOI

ADNP Is a Therapeutically Inducible Repressor of WNT Signaling in Colorectal Cancer

TL;DR: The findings indicate that ADNP is a tumor suppressor and promising prognostic marker, and that ketamine treatment with ADNP induction is a potential therapeutic approach that may add benefit to current treatment protocols for patients with colorectal cancer.
Journal ArticleDOI

Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material.

TL;DR: Results demonstrate specificity of the monoclonal cocktail for detecting the non-wild type LMP1 and the ability to sub-differentiate between the mediterranean type of LMP 1 and the CAO-LMP1.